SERVICES FOR. Devices and Combination Products



Similar documents
PEOPLE > SCIENCE > SOLUTIONS

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

Technology Transfer of CMC Activities for MAb Manufacturing ge healthcare (

Roles & Responsibilities of the Sponsor

Non-clinical development of biologics

NEW CHEMICAL ENTITIES

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials

Presented at: Jefferies 2015 Global Healthcare Conference

Spring From Our CEO. Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

ANALYTICAL OUTSOURCING WHY SHOULD YOU OUTSOURCE?

Working with ICH Quality Guidelines - the Canadian Perspective

A FDA Perspective on Nanomedicine Current Initiatives in the US

Regulatory Submission: Applying GLP in Surgical Efficacy Studies

Biopharmaceutical Process Evaluated for Viral Clearance

Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services

Selvita Integrated drug discovery collaborations

CMC Writing for IND Applications. David H. McKenna, Jr., M.D. University of Minnesota April 10-11, 2007 Workshop

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

BIOTECHNOLOGY OPERATIONS

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

Blood, Plasma, and Cellular Blood Components INTRODUCTION

US Regulations for Import and Export of Cell Therapy Products

Valentina Gualato, Ph.D. Process Development Scientist

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP

BACHELOR OF SCIENCE IN MICROBIOLOGY

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

MINISTRY OF HIGHER EDUCATION UNIVERSITY OF HAIL COLLEGE OF PHARMACY

Global Lab Capabilities Pharma Biotech

Practical Series Seminars and Workshops INTENSIVE TRAINING IN ENVIRONMENTAL MONITORING, DISINFECTANT QUALIFICATION AND CLEANROOM CONTAMINATION CONTROL

POLICY AND PROCEDURES OFFICE OF NEW DRUGS. Good Review Practice: Management of Breakthrough Therapy-Designated Drugs and Biologics.

Overview of Drug Development: the Regulatory Process

Exploiting the Pathogen box

SIPBS Portfolio Entry

The Aptuit Center for Drug Discovery & Development Verona, Italy. Uncommon Expertise. Exceptional Results.

Guidance for Industry

General Services Administration Federal Supply Service Authorized Federal Supply Schedule Price List

National curriculum and assessment guidelines in preparation for registration as a Medical Biological Scientist

Formal FDA Meeting Request: Guidance and Template

Annex 7 Guidelines on pre-approval inspections

Micromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

Pharmaceutical Wholesaler Site Inspection Checklist

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

DMPK: Experimentation & Data

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Investigational Drugs: Investigational Drugs and Biologics

Microbiology and Auditing. Don Singer

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)

Pre-market Information - Class III and IV

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

Importing pharmaceutical products to China

School of Pharmacy TEMPLE UNIVERSITY

Biotechpharma company profile

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

Medical Device Solutions. Battelle. Applied Research Device Development Clinical Research Sustaining Engineering

How to develop Antibody Drug Conjugates: Bioanalysis Contribution

ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers A WHITE PAPER

Guidance for Industry. Monoclonal Antibodies Used as Reagents in Drug Manufacturing

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers

From Research Services and Process Development to GMP Manufacturing

Integrating Good Manufacturing Practices During the Transition from Clinical Trials to Commercial Manufacturing

The Study Site Master File and Essential Documents

The Medical Device Industry in Korea: Strategies for Market Entry

Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

How To Become A State Pol Forensic Tech Leader

Cord Blood Licensure. Session 2C: Advanced Cell Therapies April 11, 2013

GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS

Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform

Extemporaneously Prepared Early Phase Clinical Trial Materials

Course Curriculum for Master Degree in Clinical Pharmacy

Operating Procedures of the PAHO Revolving Fund. for the Purchase of Vaccines, Syringes, and Other Related Supplies

Pharmacology skills for drug discovery. Why is pharmacology important?

Principal Investigator and Sub Investigator Responsibilities

CTC Technology Readiness Levels

General Information. Our Background Automated Phone Services Holiday Coverage Licenses & Accreditations

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF GLOBAL AND REGULATORY OPERATIONS AND POLICY

Providing Trusted and Innovative Solutions t o the Life Science Communities

Investor Presentation NASDAQ:BLFS

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 12. Special Issues Q&A Session. Michael Maier

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

WXPRESS. December An Integrated R&D Service Company

Medical & Health Sciences

GMP Pharma BV. Netherlands

A Stability Program for the Distribution of Drug Products

MeriCal Quality Profile

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

Pharmaceutical Sciences

NATIONAL HEALTH COUNCIL RESOLUTION Nº 251, DATED 7 AUGUST 1997

Guidance for Industry

Transcription:

SERVICES FOR Devices and Combination Products

How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta, GA 30066 FAX 770.514.0294 Philadelphia 4751 League Island Blvd. Philadelphia, PA 19112 FAX 215.218.5990 888-794-0077 651-675-2000 888-847-6633 770-514-0262 800-622-8820 215-218-5500 ACCOUNT MANAGERS Your Account Manager serves as your primary contact for all inquiries regarding testing programs and pricing. 888-794-0077 OR 651-675-2000 / Enter your Account Manager s extension or press 0 to reach the WuXi AppTec operator. EMAIL Ø WuXi AppTec personnel can be emailed at: firstname.lastname@wuxiapptec.com Or use our general mailbox: info@wuxiapptec.com INTERNET { Visit our website at: www.wuxiapptec.com. [This catalog is also available on the website.] Information in this catalog effective March 2010. 2010 WuXi AppTec. All rights reserved.

Contents Introduction to WuXi AppTec PAGE II Information for Clients PAGE IV BIOBURDEN / MICROBIAL ASSAYS Bioburden Testing Microbial Identification USP Microbiological Examination Antimicrobial Efficacy (AME) Testing In Vitro Assays Antimicrobial Efficacy (AME) Testing In Vivo Studies Antimicrobial Assays for Industrial Products BIOCOMPATIBILITY Cytotoxicity Genotoxicology / Mutagenicity Hemocompatibility Implantation Irritation / Intracutaneous Pyrogenicity Sensitization Subacute/Subchronic Toxicity Systemic (Acute) Toxicity Finished Product Release JMHLW Testing A B Reference Materials Guide to Assessing Biocompatibility Testing Needs [Chart] Testing Requirements Under GLP Regulations Required Biocompatibility Tests for Classifications of Plastics (USP) Device Categories Initial Evaluation Tests for Consideration [Chart based on ISO 10993-1 and FDA G95-1 Guidelines] Quick Guide to Sample Requirements and Turnaround Times CHEMISTRY Analytical Chemistry Chemical / Physical Tests EO Residual Testing C ENDOTOXIN (LAL) Kinetic Chromogenic LAL Tests Kinetic Turbidimetric LAL Tests Gel Clot LAL Tests ENVIRONMENTAL Environmental Monitoring Programs Microbial Sampling Tests Microbial Identification Environmental Sampling Products PACKAGE TESTING Seal Integrity Testing Package Integrity Testing Transportation/Distribution Simulation Testing Accelerated Aging / Shelf-Life Studies STERILITY TESTING Biological Indicators Sterility Method Suitability Test (B/F) Product Sterility Tests Liquid Sterility Tests Inoculated Product Tests STERILIZATION VALIDATION EO Sterilization Validation Radiation Sterilization Validation Reusable Medical Device Validation D E F G H CONTENTS WuXi AppTec I

Introduction to WuXi AppTec INTEGRATED TESTING AND MANUFACTURING SERVICES Medical Devices GLP- and GMP-compliant testing services for safety and lot release include in vivo and in vitro biocompatibility/toxicology, hemocompatibility, chemistry, microbiology, sterilization validation, viral and bacterial clearance, environmental testing, quality assurance support/monitoring of manufacturing processes, reusable device validation, package testing, and custom studies. Combination Products (Device + Drug) To meet specific needs for combination products, WuXi AppTec s GLP- and GMP-compliant testing services for efficacy, safety and lot release for medical device services are integrated with our services designed for the cell therapy, tissue, biotechnology and pharmaceutical industries. Tissue-Based Products GLP- and GMP-compliant testing services for processed tissue and tissue-based products include viral and bacterial inactivation studies, safety and lot release testing such as osteoinductivity (in vitro and in vivo), and custom studies. cgmp manufacturing services include tissue processing, R&D pilot projects, product assembly and final packaging. Biologics / Biopharmaceuticals GLP/GMP-compliant contract testing services include viral and bacterial clearance/inactivation validation studies, cell and viral bank characterization, lot release testing and stability studies with supporting virology, cell biology, microbiology, molecular biology, toxicology/in vivo and analytical laboratories. Cellular Therapeutics GLP- and GMP-compliant testing services for cellular therapeutics include viral and bacterial inactivation studies, safety and lot release testing (in vitro and in vivo) and custom studies. cgmp manufacturing services include cell line development, GMP cell banking and cell therapy technology transfer, process development and manufacturing. Pharmaceutical Industry WuXi AppTec provides integrated services for pharmaceuticals across the discovery-to-ind spectrum. Discovery services include: synthetic and medicinal chemistry, analytical chemistry, discovery biology, safety pharmacology, DMPK and ADMET, and bioanalytics. Development services include: process research and development, research and commercial manufacturing, analytical development, and pre-formulation/formulation development. WuXi AppTec also offers a full-range of in vivo and in vitro non-clinical safety evaluation (toxicology) programs. II WuXi AppTec INTRODUCTION

FACILITIES All WuXi AppTec U.S. facilities are FDA registered. Additional qualifications include ISO certification, AAALAC accreditation, FDA registration for HCT/Ps and medical devices, and accreditation by AATB. St. Paul, Minnesota This 82,000-square-foot facility houses laboratories for in vivo and in vitro biocompatibility/toxicology testing, as well as laboratories for cgmp contract manufacturing and pilot projects for processed tissue and cell/tissue-based products. Atlanta, Georgia Located in facility space of 51,000 square feet, this laboratory performs routine and custom microbiology, chemistry and package testing, with additional specialized expertise in sterilization validation studies and dose audits. Philadelphia, Pennsylvania This 75,000-square-foot building houses testing laboratories for biopharmaceuticals, as well as cell therapy manufacturing services, including cell banking and cell expansion. Testing laboratories include virology, cell biology, molecular biology, analytical and viral clearance. Global/Corporate Sites WuXi AppTec's global headquarters is located in Shanghai. Primary China-based facilities include a 782,000-square-foot R&D center, and a 22,000-square-foot cgmp-quality formulation pilot plant in Shanghai Waigaoqiao Free Trade Zone; a 293,000-square-foot cgmp-quality process development and manufacturing plant in the Jinshan area of Shanghai; a 253,000-square-foot R&D center in Tianjin; and a 314,000-square-foot toxicology center in Suzhou. QUALITY ASSURANCE Every aspect of WuXi AppTec s operations is governed by a focus on quality assurance and quality control. A highly trained, internal quality assurance unit monitors all testing to assure accuracy, precision, reliability and timeliness. A continuous quality improvement process is in place to review any discrepancies and make improvements that will consistently enhance the quality of our service. STAFFING Our staff prides itself on being the vital, dedicated human resource for expertise that enhances every service we offer. All personnel are qualified and experienced professionals. Senior technical staffing includes experts who are nationally recognized in their fields. All division directors and laboratory supervisors are highly trained with many years of experience. A well-organized and experienced reporting unit is staffed by personnel skilled in data transfer, and proficient in handling both highvolume reporting and the demands of rapid turnaround times. INTRODUCTION WuXi AppTec III

Information for Clients The following is intended to be a quick quide for answers to Frequently Asked Questions. Please contact your WuXi AppTec Account Manager for more information/details regarding these subjects or any other questions you may have about our services. CONFIDENTIALITY WuXi AppTec s entire staff is sensitive to our clients need for confidentiality regarding products, testing, and laboratory reports and data. All such information is held in strictest confidence and will be released only to persons or agencies authorized in writing by the client. [Confidentiality agreements, to be signed by the client and WuXi AppTec management, can be provided. Contact your Account Manager for more information.] Likewise, this catalog is provided with the understanding that its contents remain the property of WuXi AppTec, and that it willl be kept confidential and used only by the company or person to whom it is addressed/provided, for no other purpose than accessing information regarding the service offerings of WuXi AppTec. AUDITS We welcome the opportunity for clients to see first hand our scientific expertise and laboratory capabilities. Audits of any of our facilities may be arranged by contacting your Account Manager or the Quality Assurance Manager at the appropriate facility. SAMPLE SUBMISSION / SAMPLE HANDLING Sample Submission Samples sent to WuXi AppTec for testing should be accompanied by the appropriate paperwork for testing to be initiated. (See note below on Test Request Forms.) Where you will be submitting your sample depends on the test. As a general rule, samples for biocompatibility/in life and related testing should be sent directly to the St. Paul facility. Samples for most other services described in this catalog should be sent directly to the Atlanta facility. WuXi AppTec can accommodate sample-specific handling requirements, including centralized sample coordination, < -60 C or cryogenic handling requirements, and BSL/cleanroom accommodations. For more information regarding sample submissions, contact your Account Manager or Client Services. Test Request Forms WuXi AppTec will supply test request forms to accompany your samples in pre-printed format (for you to make copies of and fill in as necessary) or in electronic format (a PDF form you can complete and print out). To receive personalized test request form(s), contact your Account Manager or email: info@wuxiapptec.com. PDF test request forms can also be found online at www.wuxiapptec.com/trf. Online sample submission is also available via our secure client portal. For more information, please contact your Account Manager or Client Services. Sample Transportation How a sample is shipped (e.g., overnight air) is dependent on the nature of the sample and the type of testing. Some tests require that samples receive special shipping and handling (e.g., environmental water and some chemistry tests). See individual test listings or contact Client Services. IV WuXi AppTec CLIENT INFORMATION

Sample Retention and Return Samples are discarded following completion of testing unless their return is requested by the client on the test request form. Return shipments entail additional fees that may vary depending on size/weight and quantity of samples and whether they are hazardous. The Sponsor can provide a courier account number in place of incurring a return shipment fee. NOTE: Clients should be mindful of FDA and EPA GLP regulations regarding retention of samples. Retention of samples to meet these regulations is the responsibility of the Sponsor. TESTING GLP All WuXi AppTec operations are performed according to applicable good laboratory and good manufacturing practices. Certain studies for submission to regulatory bodies must be performed according to GLP (Good Laboratory Practices) regulations. GLP services are available at the client s request and entail additional fees. NOTE: For GLP tests, a protocol signed by the client must be in place at WuXi AppTec prior to test initiation. Contact your Account Manager for more information. Turnaround Time Most test listings in this catalog provide an estimated turnaround time, which is calculated as the time from test initiation at the testing facility to the time your final report is issued. Except where noted, these turnaround times are for testing that does not include GLP. GLP testing requires additional time and clients will be notified as to the date they can expect to receive their final reports. STAT Requests Arrangements can be made with the testing facility to accommodate stat testing whenever possible. Additional fees will be charged for this service. For more information, contact Client Services at the testing facility. Customized Testing WuXi AppTec is uniquely qualified to assist clients with special testing needs. Our global organization draws on scientists with many years of industry and academic experiences who provide exceptional expertise in building customized programs and performing assays in accordance with FDA, ISO, GMP, GLP, JMHLW and other guidelines. Consultation Services WuXi AppTec's expert scientific staff is available for client consultations in such areas as efficacy, safety, sterilization validations, biocompatibility, viral clearance, environmental monitoring, quality systems, and regulatory testing requirements. Contact your Account Manager for more information regarding rates and availability. CONTINUED NEXT PAGE CLIENT INFORMATION WuXi AppTec V

REPORTS Test Results Reporting Test reports include sample description, reference to a protocol or procedure, calculation methods when applicable, data summaries and a conclusion as applicable. Unexpected test results are reported promptly to the client. In the interest of accuracy, and to avoid possible miscommunication, we advise clients to rely on written reports for routine testing rather than requesting results by phone. Amended or Re-Issued Reports If, at the client's request, a test report is amended and a new report is issued, or if the client requests that WuXi AppTec re-issue a report, additional fees will apply. Record Retention Copies of test reports are retained in a secure archive managed by WuXi AppTec s Quality Assurance department. PAYMENT Pricing Clients should contact their Account Manager regarding all pricing information. Purchase Orders / Billing Submitted samples should be accompanied by a purchase order (P.O.) number. Testing projects of unusual length or complexity may require initial, partial and/or interim payment. Credit applications may be required of new clients and WuXi AppTec may require new clients to make a payment in advance of test initiation. Invoices are billed and payable in U.S. dollars only. Payment for all invoices is net 30 days. VI WuXi AppTec CLIENT INFORMATION